HMGA2 staining data were unrelated to parameters of cancer aggressiveness in hepatocellular carcinoma, squamous cell carcinomas of different sites of origin, muscle-invasive urothelial carcinoma, serous high-grade carcinoma of the ovary, as well as in gastric and pancreatic adenocarcinoma. This evidence concerns the gene HMGA2 and cancer.